Off-label use of repurposed ivermectin for SARS-CoV-2 infection should be banned by authorities unless efficacy is proven
ABSTRACT
Abstract is not available. Click DOWNLOAD to read full text.
ABSTRACT
Abstract is not available. Click DOWNLOAD to read full text.